Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.87% |
| 2 | Technology | 11.53% |
| 3 | Consumer Discretionary | 11.36% |
| 4 | Healthcare | 11.05% |
| 5 | Industrials | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PENG
1701
Penguin Solutions Inc
PENG
$2.24B
| $5.49M | 0.01% |
325,534
+304,736
| +1,465% | +$4.83M |
|
1702
Tilly's
TLYS
$114M
| $5.47M | 0.01% |
370,804
+245,115
| +195% | +$3.29M |
|
1703
Dine Brands
DIN
$462M
| $5.45M | 0.01% |
107,341
-5,123
| -5% | -$239K |
|
1704
Telkom Indonesia
TLK
$14.2B
| $5.44M | 0.01% |
168,727
+158,216
| +1,505% | +$4.95M |
|
1705
Capri Holdings
CPRI
$1.82B
| $5.42M | 0.01% |
86,163
+73,630
| +587% | +$4.04M |
|
1706
PUT
Kohl's
KSS
$2.16B
| $5.42M | 0.01% |
+100,000
| New | +$4.6M |
|
|
HSII
1707
DELISTED
Heidrick & Struggles
HSII
| $5.41M | 0.01% |
220,421
+150,127
| +214% | +$3.52M |
|
|
GNC
1708
DELISTED
GNC Holdings, Inc.
GNC
| $5.41M | 0.01% |
1,465,258
+1,409,237
| +2,516% | +$8.86M |
|
|
BIVV
1709
CALL
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $5.39M | 0.01% |
+100,000
| New | +$5.47M |
|
|
ADAP
1710
DELISTED
Adaptimmune Therapeutics
ADAP
| $5.38M | 0.01% |
805,595
+215,439
| +37% | +$1.66M |
|
1711
Visteon
VC
$2.85B
| $5.37M | 0.01% |
42,927
+16,515
| +63% | +$2.09M |
|
1712
CALL
Celanese
CE
$4.82B
| $5.35M | 0.01% |
50,000
+7,500
| +18% | +$797K |
|
|
CLR
1713
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $5.3M | 0.01% |
+100,000
| New | +$4.39M |
|
|
LTRPA
1714
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $5.3M | 0.01% |
561,888
+284,369
| +102% | +$2.92M |
|
|
PRTK
1715
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $5.29M | 0.01% |
295,622
-38,731
| -12% | -$808K |
|
|
PVLA
1716
Palvella Therapeutics
PVLA
$2.05B
| $5.28M | 0.01% |
8,747
+3,208
| +58% | +$1.49M |
|
1717
CALL
Colgate-Palmolive
CL
$74.8B
| $5.28M | 0.01% |
70,000
-130,000
| -65% | -$9.49M |
|
1718
FirstService
FSV
$6.55B
| $5.25M | 0.01% |
75,162
+47,684
| +174% | +$3.28M |
|
|
AZPN
1719
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $5.25M | 0.01% |
79,253
-289,500
| -79% | -$19.2M |
|
|
SINA
1720
DELISTED
Sina Corp
SINA
| $5.25M | 0.01% |
52,287
-145,474
| -74% | -$15.5M |
|
1721
Monarch Casino & Resort
MCRI
$2.2B
| $5.24M | 0.01% |
116,937
+81,798
| +233% | +$3.63M |
|
1722
Bank of Marin Bancorp
BMRC
$460M
| $5.23M | 0.01% |
153,924
+96,872
| +170% | +$3.34M |
|
1723
AMERISAFE
AMSF
$562M
| $5.21M | 0.01% |
84,624
+43,937
| +108% | +$2.76M |
|
1724
ArcBest
ARCB
$3.15B
| $5.21M | 0.01% |
145,821
+49,894
| +52% | +$1.7M |
|
1725
Iovance Biotherapeutics
IOVA
$2.04B
| $5.2M | 0.01% |
649,651
-1,431,829
| -69% | -$11.5M |
|
Similar funds
Millennium Management's Q4 2017 Portfolio in Review
As of Q4 2017, Millennium Management held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Millennium Management deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Millennium Management's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Millennium Management's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Millennium Management fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Millennium Management's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Millennium Management opened 897 new positions and closed 601 in Q4 2017.
- Millennium Management's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.